Red Light Therapy in Thrombosis and Hemostasis
Seminars in Thrombosis and Hemostasis · 01.03.2026 · 52 (02) · 266-272
DOI: 10.1055/a-2717-5157 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Seminars in Thrombosis and Hemostasis, erschienen am 01.03.2026. Verfasst von Bingwen Eugene Fan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Haematology, Tan Tock Seng Hospital, Singapore. Hauptthemen laut MEDLINE: Thrombosis, Hemostasis, Phototherapy. Die Arbeit nennt 21 Literaturangaben.
Abstract (Originalsprache)
Red light therapy is emerging as a potential non-pharmacological modulator of thrombosis and hemostasis. Photobiomodulation with red, near-infrared (NIR), and far-infrared (FIR) wavelengths has been shown to influence nitric oxide release, endothelial function, platelet activation, and vascular tone. These effects align with the components of Virchow's triad (i.e., endothelial dysfunction, stasis, and hypercoagulability), and ameliorate thromboinflammation. Experimental data indicate that photobiomodulation may be effective to reduce platelet aggregation, von Willebrand factor activity, and improve microvascular perfusion. However, controversy remains regarding whether observed benefits reflect active red/NIR effects or simply the exclusion of pro-thrombotic blue light. Limitations in tissue penetration, protocol standardization, and translational modeling pose challenges for clinical implementation. Despite these uncertainties, red light therapy offers promise in high-risk patients where conventional anticoagulation is limited by bleeding risk. Future studies must define optimal dosing parameters, clarify mechanistic pathways, and evaluate efficacy in randomized clinical trials to establish its role in contemporary thrombosis management.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Haematology, Tan Tock Seng Hospital, Singapore.
- Lee Kong Chian School of Medicine, Singapore.
- Department of Laboratory Medicine, Khoo Teck Puat Hospital, Singapore.
- Yong Loo Lin School of Medicine, Singapore.
- Sydney Centres for Thrombosis and Haemostasis, Institute of Clinical Pathology and Medical Research (ICPMR), Research and Education Network (REN), Westmead Hospital, Westmead, Australia.
- Westmead Clinical School, University of Sydney, Westmead Hospital, Westmead, New South Wales, Australia.
Zitieren
APA
Fan, B. E., Pasalic, L., Hew, Y. Y., Lippi, G., & Favaloro, E. J. (2026). Red Light Therapy in Thrombosis and Hemostasis. Seminars in Thrombosis and Hemostasis, 52(02), 266-272. https://doi.org/10.1055/a-2717-5157
Vancouver
Fan BE, Pasalic L, Hew YY, Lippi G, Favaloro EJ. Red Light Therapy in Thrombosis and Hemostasis. Seminars in Thrombosis and Hemostasis. 2026;52(02):266-272. doi:10.1055/a-2717-5157
BibTeX
@article{Fan2026,
author = {Fan, Bingwen Eugene and Pasalic, Leonardo and Hew, Yu Yue and Lippi, Giuseppi and Favaloro, Emmanuel J},
title = {Red Light Therapy in Thrombosis and Hemostasis},
journal = {Seminars in Thrombosis and Hemostasis},
year = {2026},
volume = {52},
number = {02},
pages = {266--272},
doi = {10.1055/a-2717-5157}
}
EUVIMED